Van Leeuwen & Company, LLC Dexcom Inc Transaction History

Van Leeuwen & Company, LLC

  • $196 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Feb 06, 2024
BUY
$112.47 - $130.98 $1.75 Million - $2.04 Million
15,579 New
15,579 $2 Million
Q2 2023

Aug 07, 2023
BUY
$112.47 - $130.98 $1.75 Million - $2.04 Million
15,579 New
15,579 $1.98 Million
Q3 2020

Nov 13, 2020
SELL
$95.51 - $112.95 $79,941 - $94,539
-837 Closed
0 $0
Q2 2020

Aug 03, 2020
BUY
$62.68 - $105.34 $52,463 - $88,169
837 New
837 $339,000

Others Institutions Holding DXCM

# of Institutions
1,080
Shares Held
376M
Call Options Held
6.76M
Put Options Held
7.24M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Van Leeuwen & Company, LLC Portfolio

Follow Van Leeuwen & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Leeuwen & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Leeuwen & Company, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email